Search

Your search keyword '"Allen DG"' showing total 471 results

Search Constraints

Start Over You searched for: Author "Allen DG" Remove constraint Author: "Allen DG"
471 results on '"Allen DG"'

Search Results

1. OPERA models to support regulatory needs

2. Virucidal Efficacy of Guanidine-Free Inactivants and Rapid Test Buffers Against SARS-CoV-2: Implications for Risk Assessment of Diagnostic Procedures

4. Corona crisis and inequality: Why management research needs a societal turn

6. P2X7 Receptors Mediate Innate Phagocytosis by Human Neural Precursor Cells and Neuroblasts

7. A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer

8. Okadaic acid, a protein phosphatase inhibitor, increases the calcium transients in isolated ferret ventricular muscle

9. Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer.

19. Should I stay or should I go? The role of risk in employee turnover decisions.

20. Whiteness and difference in nursing.

22. Residual value of superphosphate and Queensland rock phosphate for serradella and clover on very sandy soils as assessed by plant growth and bicarbonate-soluble phosphorus

23. Storage of air-dry soil samples at 0 degrees C or at room temperature before analysis does not affect bicarbonate soil-test phosphorus

24. Comparison of seven phosphorus sorption indices

25. Effect of P-buffer capacity and P-retention index of soils on soil test-P, soil test P-calibrations and yield response curvature

26. Synthesis and resolution of an asymmetric arsonium cation. Crystal and molecular structures of (R)-Benzyl(methyl)(4-methylphenyl)(naphthalen-1-yl)- arsonium bromide and hexafluorophosphate

27. Studies of the contractility of mammalian myocardium at low rates of stimulation

30. Distribution of extracellular adhesins in environmental biofilms and flocs: Reimagining the microbial structure.

31. Human relevance of in vivo and in vitro skin irritation tests for hazard classification of pesticides.

32. Integrated Approach for Testing and Assessment for Developmental Neurotoxicity (DNT) to Prioritize Aromatic Organophosphorus Flame Retardants.

33. A review of emerging membrane-based microalgal-bacterial processes for wastewater treatment: Process configurations, biological and membrane performance, and perspectives.

34. Differences in the anatomy and physiology of the human and rat respiratory tracts and impact on toxicological assessments.

35. Use of human predictive patch test (HPPT) data for the classification of skin sensitization hazard and potency.

36. Roles of pH and phosphate in rare earth element biosorption with living acidophilic microalgae.

37. Defined approaches to classify agrochemical formulations into EPA hazard categories developed using EpiOcular TM reconstructed human corneal epithelium and bovine corneal opacity and permeability assays.

38. A Light Touch: Solar Photocatalysis Detoxifies Oil Sands Process-Affected Waters Prior to Significant Treatment of Naphthenic Acids.

39. A database of human predictive patch test data for skin sensitization.

40. Human cell-based in vitro systems to assess respiratory toxicity: a case study using silanes.

41. International regulatory uses of acute systemic toxicity data and integration of new approach methodologies.

42. Determining the performance of lignin-based flocculants in improving biosludge dewaterability.

43. Application of Defined Approaches to Assess Skin Sensitization Potency of Isothiazolinone Compounds.

45. Replacement of in vivo leptospirosis vaccine potency testing in the United States.

46. Mixtures-Inclusive In Silico Models of Ocular Toxicity Based on United States and International Hazard Categories.

47. Application of Defined Approaches for Skin Sensitization to Agrochemical Products.

48. IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making.

49. Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0).

50. U.S. Federal Agency interests and key considerations for new approach methodologies for nanomaterials.

Catalog

Books, media, physical & digital resources